Furthermore, the identification and better underpinning of altered signaling pathways such as STAT-1 and AKT/AMPK could have several therapeutical implications, not only in COVID-19 but also in other thrombotic states associated with a wide spectrum of infectious diseases. This evidence concerns the gene STAT1 and COVID-19.